Your browser doesn't support javascript.
Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children.
Morin, Sébastien; Lallemant, Marc; Garcia-Prats, Anthony; Lewis, Linda; Watkins, Melynda; Giaquinto, Carlo; Valentin, Marie; Penazzato, Martina; Reeder, John C.
  • Morin S; From the Medicines Patent Pool, Geneva, Switzerland.
  • Lallemant M; Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Garcia-Prats A; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Lewis L; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Watkins M; Department of Women and Child Health, University of Padova, Padova, Italy.
  • Giaquinto C; Department of Women and Child Health, University of Padova, Padova, Italy.
  • Valentin M; World Health Organization, Geneva, Switzerland.
  • Penazzato M; World Health Organization, Geneva, Switzerland.
  • Reeder JC; World Health Organization, Geneva, Switzerland.
Pediatr Infect Dis J ; 41(1): e1-e5, 2022 01 01.
Article in English | MEDLINE | ID: covidwho-1522380
ABSTRACT
Children, although at lower risk of poor outcomes from COVID-19 relative to adults, still stand to benefit from therapeutic interventions. Understanding of COVID-19 clinical presentation and prognosis in children is essential to optimize therapeutic trials design. This perspective illustrates how to collectively accelerate pediatric COVID-19 therapeutic research and development, based on the experience of the Global Accelerator for Paediatric Formulations.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Research / Seizures / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Child / Humans Language: English Journal: Pediatr Infect Dis J Journal subject: Communicable Diseases / Pediatrics Year: 2022 Document Type: Article Affiliation country: INF.0000000000003331

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Research / Seizures / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Child / Humans Language: English Journal: Pediatr Infect Dis J Journal subject: Communicable Diseases / Pediatrics Year: 2022 Document Type: Article Affiliation country: INF.0000000000003331